Highlights
World IBD Day 2025: IBD Has No Borders: Breaking Taboos, Talking About It
Building on last year’s theme, “IBD Has No Borders,” we will continue our journey into 2025, focusing on : “IBD Has No Borders: Breaking Taboos, Talking About It.” ...
Young Voices Matter: Take Our IBD Survey!
Are you 18 to 30 years old and living with IBD? We want to hear from you!
Big news: A long-awaited approval for an advanced pediatric IBD treatment!
The European Medicines Agency (EMA) recently adopted a positive opinion extending the use of Stelara (ustekinumab) for children with Crohn’s disease who weigh at least 40kg.
EFCCA Conference at ECCO Congress 2025 in Berlin
On 20 February 2025, at the 20th ECCO Congress in Berlin, we hosted our conference: "What do IBD patients find important in their treatment? Results from a global Patient Preference survey."
New European Research Project “PerPrev-CID”
Aiming to revolutionise personalised prevention and early treatment in chronic inflammatory diseases (CIDs), the PerPrev-CID project focuses on advancing risk prediction, early detection of disease progression, and innovative preventive approaches in...
EFCCA Talk: "Living with Fibrosis: Challenges, Treatments and Innovations"
EFCCA brought together top researchers, industry experts and patient advocates for a webinar on intestinal fibrosis in IBD
EFCCA Magazine 1/2025
The latest edition of EFCCA Magazine is here, packed with updates on what EFCCA has been working on over the past months, insights from our member associations, and an article by Professor Claudio Fiocchi...
EFCCA Talk: IUS - Intestinal Ultrasound, a Promising Alternative to Endoscopy?
This non-invasive technique is emerging as a valuable tool for diagnosis, treatment, and disease monitoring in IBD patients.
Stay connected: Follow us on Instagram!
As we embark on a new year, our communication team has been working behind the scenes to bring you closer to the EFCCA community.
Patients Participation in HTA: Final Report Released
Following the success of our HTA conference at UEGW last October, EFCCA is pleased to share the final report from a two-round consultation with stakeholders and experts.